LifeMD Inc (NASDAQ:LFMD) — Market Cap & Net Worth
Market Cap & Net Worth: LifeMD Inc (LFMD)
LifeMD Inc (NASDAQ:LFMD) has a market capitalization of $189.41 Million ($189.41 Million) as of May 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16746 globally and #3786 in its home market, demonstrating a 10.13% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LifeMD Inc's stock price $5.00 by its total outstanding shares 48135885 (48.14 Million). Analyse how efficiently does LifeMD Inc generate cash to see how efficiently the company converts income to cash.
LifeMD Inc Market Cap History: 2015 to 2026
LifeMD Inc's market capitalization history from 2015 to 2026. Data shows growth from $28.88 Million to $240.68 Million (24.42% CAGR).
Index Memberships
LifeMD Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.41 Trillion | 0.01% | #460 of 976 |
|
NASDAQ Composite
IXIC
|
$38.77 Trillion | 0.00% | #1647 of 3165 |
Weight: LifeMD Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
LifeMD Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LifeMD Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.85x
LifeMD Inc's market cap is 0.85 times its annual revenue
Latest Price to Earnings (P/E) Ratio
14.59x
LifeMD Inc's market cap is 14.59 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $62.58 Million | $5.24 Million | -$1.11 Million | 11.95x | N/A |
| 2017 | $81.83 Million | $5.05 Million | -$1.21 Million | 16.19x | N/A |
| 2018 | $33.70 Million | $8.32 Million | -$1.24 Million | 4.05x | N/A |
| 2019 | $28.88 Million | $12.47 Million | -$3.14 Million | 2.32x | N/A |
| 2020 | $314.33 Million | $37.29 Million | -$60.52 Million | 8.43x | N/A |
| 2021 | $186.29 Million | $92.88 Million | -$60.90 Million | 2.01x | N/A |
| 2022 | $93.38 Million | $119.03 Million | -$45.54 Million | 0.78x | N/A |
| 2023 | $399.05 Million | $152.55 Million | -$20.60 Million | 2.62x | N/A |
| 2024 | $238.27 Million | $212.45 Million | -$18.88 Million | 1.12x | N/A |
| 2025 | $164.14 Million | $194.06 Million | $11.25 Million | 0.85x | 14.59x |
Competitor Companies of LFMD by Market Capitalization
Companies near LifeMD Inc in the global market cap rankings as of May 3, 2026.
Key companies related to LifeMD Inc by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #926 globally with a market cap of $28.21 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #2225 globally with a market cap of $10.06 Billion USD ( AU$14.22 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2339 globally with a market cap of $9.34 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2447 globally with a market cap of $8.82 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #926 | Veeva Systems Inc Class A | NYSE:VEEV | $28.21 Billion | $171.60 |
| #2225 | Pro Medicus Ltd | AU:PME | $10.06 Billion | AU$136.16 |
| #2339 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $9.34 Billion | $55.00 |
| #2447 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $8.82 Billion | $52.58 |
LifeMD Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, LifeMD Inc's market cap moved from $28.88 Million to $ 240.68 Million, with a yearly change of 24.42%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $240.68 Million | +46.63% |
| 2025 | $164.14 Million | -31.11% |
| 2024 | $238.27 Million | -40.29% |
| 2023 | $399.05 Million | +327.32% |
| 2022 | $93.38 Million | -49.87% |
| 2021 | $186.29 Million | -40.74% |
| 2020 | $314.33 Million | +988.33% |
| 2019 | $28.88 Million | -14.29% |
| 2018 | $33.70 Million | -58.82% |
| 2017 | $81.83 Million | +30.77% |
| 2016 | $62.58 Million | +116.67% |
| 2015 | $28.88 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of LifeMD Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $189.41 Million USD |
| MoneyControl | $189.41 Million USD |
| MarketWatch | $189.41 Million USD |
| marketcap.company | $189.41 Million USD |
| Reuters | $189.41 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About LifeMD Inc
LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature e… Read more